Man Saved From Blindness By Gene Therapy.

http://abcnews.go.com/Health/man-saved-blindness-gene-therapy/story?id=21578118&singlePage=true


help Courtesy Nick Tuftnell 
At age 10 Nick Tuftnell knew he was going to end up blind after being diagnosed 
with the genetic condition choroideremia. 
The condition leads to the death of light-absorbing cells in the eye. The cells 
die because of a mutated gene in certain ocular cells, which eventually leads 
to blindness. 
“I knew my granddad had it. I remember seeing him in the latter stages of life 
and he was completely blind,” said Tuftnell, now 38. 
After his condition was confirmed, Tuftnell said he had nothing to do but wait 
for his eyesight to slowly dim and darken over time. 
“All the doctors could say is ‘Your son is going to go blind, see you later,’” 
said Tufnell of receiving his diagnosis. 
As he grew older his eyesight has diminished to the point where he can no 
longer drive due to poor peripheral vision and has severe difficulty moving 
around at night. 
“I can’t walk around at night, it’s that bad,” said Tuftnell. “I don’t have any 
peripheral vision…eventually it’ll get like I’m looking through toilet rolls.” 
Tuftnell said his doctors estimated that he had around “ten years of useful 
vision left.” 
However, two years ago Tuftnell took part in a groundbreaking study where gene 
therapy was used to treat his deteriorating condition. 
The results of the study were published last week in the Lancet Medical 
Journal. 
Tuftnell was one of six patients in a study from the University of Oxford, who 
underwent gene therapy to help stop the deterioration caused by choroideremia. 
To help the dying ocular cells, doctors injected working versions of the gene 
into Tuftnell's eye. The gene can then start to “fix” the cells by patching 
missing genetic data. 
Virus particles were used to deliver the genes in fluid behind the retina. 
Dr. Robert MacLaren, professor of ophthalmology at the University of Oxford and 
lead author of the study, said all the patients had choroideremia, which would 
eventually have left them blind. 
“The key thing about our study that is new is that we’ve gone in before they 
lost their visual acuity,” said MacLaren, who pointed out that two patients had 
20/20 vision before the surgery. “The best way to fix [cells is to] put in the 
missing gene before they die.” 
MacLaren said he warned participants that undergoing the operation for the 
study could mean their vision was more impaired than before the surgery. 
“I talked to them and said you’re going to be like one of the first 
astronauts,” said MacLaren. 
The treatment included an operation that would temporarily involve detaching 
Tuftnell’s retina. It’s a procedure that is done only in the rarest of 
circumstances because it can result in permanent damage to the patient’s 
eyesight. 
Tuftnell said after meeting with MacLaren and the other researchers he decided 
to take the risk. 
An additional factor that led Tuftnell to want to try the surgery was the fact 
that he had just lost his wife to cancer six months earlier. 
Tuftnell said he felt he had to try, “any chance I’ve got of trying to save" 
his vision to stay active with his now 5-year-old son Theo. 
Gene Therapy Gives Hope to the Blind 
According to the study, two of the patients with worse eyesight than Tuftnell 
had their vision significantly improved by the surgery. The other four, 
including Tuftnell, had their night vision improve or kept their eyesight in 
the treated eye at the same level. 
While MacLean said it is too early to tell if the therapy will be permanent, he 
said none of the participants had continued deterioration in the treated eye. 
MacLean said going forward he hopes to expand the study to clinics in America 
and Canada. 
Additionally he hopes the study means new research into similar treatments for 
other common causes of blindness such as macular degeneration or glaucoma. 
Tuftnell said his treated eye has improved slightly, but his untreated eye has 
continued to deteriorate. 
“It’s like being given an arm back that you’ve lost,” said Tuftnell of his new 
prognosis. 




Time to meet up again!
Register for AccessIndia Convention 2014:
http://accessindia.org.in/harish/convention.htm



Register at the dedicated AccessIndia list for discussing accessibility of 
mobile phones / Tabs on:
http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in


Search for old postings at:
http://www.mail-archive.com/accessindia@accessindia.org.in/

To unsubscribe send a message to
accessindia-requ...@accessindia.org.in
with the subject unsubscribe.

To change your subscription to digest mode or make any other changes, please 
visit the list home page at
http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in


Disclaimer:
1. Contents of the mails, factual, or otherwise, reflect the thinking of the 
person sending the mail and AI in no way relates itself to its veracity;

2. AI cannot be held liable for any commission/omission based on the mails sent 
through this mailing list..

Reply via email to